Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
Chronic lymphocytic leukemia (CLL) is a disorder with multiple defects leading to an increased susceptibility to infection. Hypogammaglobulinemia is present in about 20% to 70% of patients with CLL. Intravenous immunoglobulin (IVIG) supplementation (400 mg/kg body weight every 3 weeks) prevented bac...
| المؤلفون الرئيسيون: | , , , , , , , , |
|---|---|
| التنسيق: | Conference item |
| منشور في: |
1991
|